Vips-Med

History

2024: Construction of an enterprise in the Moscow region for the production of drugs for gastrointestinal research

In the city district of Fryazino, Moscow Region, the Vips-Med company completed the construction of a production and warehouse complex for the production of a radiopaque contrast agent used in gastrointestinal tract studies. The object was erected on a site received as part of the regional import substitution program "Earth for 1 ruble." This became known on October 24, 2024.

According to the press service of the Ministry of Investment, Industry and Science of the Moscow Region, the volume of investments in construction amounted to ₽80 million. The start of production is scheduled until the end of 2024 after obtaining an appropriate license from the Ministry of Industry and Trade of Russia.

𝓲

mii.mosreg.ru

Deputy Prime Minister - Minister of Investment, Industry and Science of the Moscow Region Ekaterina Zinovieva said that 20 jobs will be created at the new enterprise, and production will ensure the production of a vital drug for the Russian health care system.

The company "Vips-Med" is the only manufacturer in Russia of Bar-VIPS radiopaque agent based on barium sulfate for the study of the gastrointestinal tract. There are no analogues of this drug on the Russian market.

According to the press service, the company plans to increase the annual production of Bar-VIPS to 200 tons. The drug is included in the list of vital and essential drugs, which emphasizes its strategic importance for domestic healthcare.

In addition to radiopaque products, VIPS-MED produces various types of drugs, medical equipment, surgical tables and other medical products, contributing to the development of import substitution in the pharmaceutical industry of Russia.^[1]

Notes